Lasa Supergenerics Limited share price
NSE: LASA
Key numbers
- Market cap
- ₹ 29.5 Cr
- Current price
- ₹ 5.89
- 52-week high / low
- ₹ 12 / 6
- Stock P/E
- -
- Book value
- ₹ 9.9
- Dividend yield
- 0.00%
- ROCE
- -47.1%
- ROE
- -51.1%
- Debt to equity
- 0.20
- Sales growth (3 yrs)
- -42.1%
- Profit growth (3 yrs)
- -
- 1-year return
- -53.0%
About Lasa Supergenerics Limited
Lasa Supergenerics Limited engages in the manufacturing API bulk drugs products in India and internationally. It offers API products, such as fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, 2,6-diiodo-4-nitrophenol, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide; and Other API products. The company also provides animal feed ingredients; and reagents for therapeutic use. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 20 | 3 | 2 | -0 | 1 |
| Operating profit | -1 | -4 | -1 | -2 | -1 |
| Net profit | -21 | -6 | -3 | -4 | -4 |
| EPS (₹) | -4.22 | 1.25 | -0.51 | -0.83 | -0.71 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.